High-yield points
- Surgery beats medicine in RCTs: 58% vs. 8% in adults; 77% vs. 7% in children . Operate early .
- 2026 AES/CNS guideline: ATL is the strong recommendation for MTLE; SAH and LITT are conditional .
- ATL vs. SAH:
- Seizure freedom: ATL edges ahead (NNT about 13) in one meta-analysis, but not in a network meta-analysis .
- IQ: SAH confers no IQ advantage .
- LITT:
- Engel I: about 55–60% (56% at 1 year in the prospective SLATE trial), falling to about 49% long term .
- Cognition: naming spared.
- Recovery: home in about 1 day.
- Failures: ATL rescues them .
- Biggest cognitive risk: left mesial resection with left language and intact preoperative memory .
- Quadrantanopia is common on formal perimetry after both ATL and SAH (about 75%) but usually asymptomatic .
Landmark papers
- Wiebe et al. (N Engl J Med 2001): randomized trial of surgery vs medical therapy for temporal lobe epilepsy in adults. Seizures that impair awareness stopped in 58% vs 8% at 1 year .
- ERSET (Engel et al., JAMA 2012): randomized trial of early surgery in drug-resistant mesial temporal lobe epilepsy. Seizure-free in year 2 in 11 of 15 with surgery vs 0 of 23 with continued medication .
- Dwivedi et al., N Engl J Med 2017: pediatric randomized trial of surgery vs medical therapy (all lesion types). 77% vs 7% seizure-free at 12 months .
Temporal lobe epilepsy (TLE) is the most surgically rewarding epilepsy.
- Randomized evidence: surgery beats medicine :
- Adults: 58% vs. 8% free of seizures that impair awareness at 1 year.
- Early mesial TLE: 11 of 15 vs. 0 of 23 seizure-free in year 2.
- Children (all lesion types): 77% vs. 7% seizure-free at 12 months.
- 2026 AES/CNS guideline :
- Strong recommendation: anterior temporal lobectomy (ATL) for mesial temporal lobe epilepsy (MTLE) at low risk of cognitive decline.
- Conditional recommendations: ATL at high cognitive risk, selective amygdalohippocampectomy (SAH), and laser interstitial thermal therapy (LITT), with shared decision-making.
- The central trade-off: seizure freedom (ATL first) vs. cognitive preservation (SAH and LITT), weighed most carefully for dominant-hemisphere surgery .
Indications and workup
- Candidate:
- drug-resistant focal seizures of temporal origin, after failure of 2 appropriate medications;
- concordant semiology, video-EEG, MRI and, when needed, PET, SPECT, MEG or stereo-EEG.
- Operate early. In ERSET, patients within 2 years of drug resistance became seizure-free with surgery (11 of 15) but not with continued medication (0 of 23) .
- Pathology differs in children (70 children after temporal lobectomy) :
- Hippocampal sclerosis: ILAE type 1 in 54%, type 3 in 30%, none in 13%.
- Dual pathology: 33%, most often type 3 sclerosis with a low-grade epilepsy-associated tumor.
- Under 12 years: tumors were the commonest cause, whereas prolonged febrile seizures dominated after 12.
- Seizure-free at final follow-up: 74.3%, with no difference by sclerosis type.
- Cognitive risk assessment:
- neuropsychology;
- language lateralization by fMRI or Wada;
- memory testing.
- Highest risk: intact preoperative memory, with left language dominance .
Techniques
- Anterior temporal lobectomy (ATL):
- Lateral neocortex: resection from the temporal pole, sparing the superior temporal gyrus as appropriate, especially on the dominant side.
- Mesial structures: amygdala, hippocampus and parahippocampal gyrus.
- Neocortical extent: customarily less on the dominant side (see caveats).
- Selective amygdalohippocampectomy (SAH):
- What it removes: the mesial structures only, through a transsylvian, transcortical (middle temporal gyrus) or subtemporal corridor.
- Its aim: to spare the lateral neocortex.
- LITT (stereotactic laser amygdalohippocampotomy):
- Approach: an occipital-entry fiber along the long axis of the hippocampus.
- What works: in 234 patients, effective ablations were anterior, medial and inferior, covering the amygdala, then the hippocampal head, parahippocampal gyrus and rhinal cortices. Extending posteriorly added little .
- Recovery: median stay 1 day in a prospective registry .
- Details are in LITT in Epilepsy Surgery.
Seizure outcomes
- ATL vs. SAH:
- Meta-analysis of 13 studies (1,203 patients): Engel I was more likely after ATL (RR 1.32; risk difference 8%, number needed to treat 13) .
- Second meta-analysis: SAH reduced the odds of seizure freedom (OR 0.65), with no IQ advantage .
- Network meta-analysis of 28 studies: no significant difference (OR 1.14). Both were far better than medical therapy (OR about 28) .
- LITT for MTLE:
- Engel I:
- 53.4% at 1 year (60.5% with mesial temporal sclerosis vs. 33.3% without) ;
- 58% in 234 patients ;
- 58.4% at 2 years in a prospective registry of 145 patients, with similar results in patients under 22 ;
- 56.0% at 12 months (95% CI 46.2–65.8) in SLATE, the prospective multicenter pivotal trial (114 treated adults aged 18–70) .
- Durability (268 patients) :
- Engel I over time: 55.8% at 1 year, 49.3% at a median of 47 months.
- Rescue after failure: ATL made 66.7% seizure-free, and repeat LITT 50%.
- Children (19 patients aged 8–20): Engel I 73.5%, and 90% with MRI hippocampal sclerosis .
- Children overall: 74% were seizure-free after pediatric temporal resection . In the pediatric RCT (all lesion types), 77% of operated children were seizure-free at 12 months .
Complications
- Verbal memory:
- Children (63 temporal resections) :
- Who declined: only children with left resections that included the mesial structures.
- Where risk was highest: with left language representation and intact preoperative memory.
- Sparing the mesial structures prevented decline.
- ERSET: memory declined in 36% after anteromesial resection .
- Naming: after dominant-side open resection, 21 of 22 patients declined in naming, vs. none after LITT . In SLATE, Boston Naming and verbal learning scores at 12 months were non-inferior to baseline .
- Visual field deficits (formal perimetry) :
- Superior quadrantanopia at 40°: 73% after ATL and 78% after SAH, not significantly different.
- Mechanism: injury to Meyer's loop while reaching the mesial structures.
- Symptoms: all patients were asymptomatic.
- Neurologic deficit:
- Pediatric RCT: serious adverse events in 33%, including hemiparesis in 26%. These were the expected deficits of resections across all lesion types, not temporal lobectomy alone .
- Adult RCT: 10% had adverse effects of surgery .
- LITT:
- Prospective registry: adverse events in 16.5%, mostly mild .
- SLATE: qualifying (moderate-to-severe, permanent, device- or procedure-related) adverse events in 7.9% .
- Other risks (see caveats):
- superior quadrantanopia;
- third and fourth nerve palsy;
- injury to the anterior choroidal or posterior cerebral artery branches, or to perforators;
- infection;
- mood changes.
Choosing the operation
- Non-dominant MTLE, or dominant MTLE with already-impaired memory: ATL gives the best chance of seizure freedom .
- Dominant MTLE with intact memory:
- consider LITT or SAH to preserve naming and memory;
- accept a lower, rescuable seizure-freedom rate .
- Lesional TLE in children (tumor, cortical dysplasia, dual pathology): tailor the resection to the lesion and the epileptogenic zone .
- Failed LITT: ATL rescues most .
Related topics
- LITT in Epilepsy Surgery: laser amygdalohippocampotomy details.
- Intracranial EEG: when invasive monitoring is needed.
- Brain Mapping: language mapping.
- Epilepsy Surgery Overview: surgical context.
References
- Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345(5):311–318. doi:10.1056/NEJM200108023450501. PMID 11484687. verified
- Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012;307(9):922–930. doi:10.1001/jama.2012.220. PMID 22396514. verified
- Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for drug-resistant epilepsy in children. N Engl J Med 2017;377(17):1639–1647. doi:10.1056/NEJMoa1615335. PMID 29069568. verified
- Jobst BC, Bergey G, Roldán-Benítez YM, et al. American Epilepsy Society/Congress of Neurological Surgeons epilepsy surgery clinical practice guideline. Epilepsy Curr 2026. doi:10.1177/15357597261465347. PMID 42948139. verified
- Josephson CB, Dykeman J, Fiest KM, et al. Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology 2013;80(18):1669–1676. doi:10.1212/WNL.0b013e3182904f82. PMID 23553475. verified
- Gross RE, Stern MA, Willie JT, et al. Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Ann Neurol 2018;83(3):575–587. doi:10.1002/ana.25180. PMID 29420840. verified
- Law N, Benifla M, Rutka J, Smith ML. Verbal memory after temporal lobe epilepsy surgery in children: do only mesial structures matter? Epilepsia 2017;58(2):291–299. doi:10.1111/epi.13635. PMID 28012164. verified
- Drane DL, Loring DW, Voets NL, et al. Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia 2015;56(1):101–113. doi:10.1111/epi.12860. PMID 25489630. verified
- Günbey C, Söylemezoğlu F, Bilginer B, et al. International consensus classification of hippocampal sclerosis and etiologic diversity in children with temporal lobectomy. Epilepsy Behav 2020;112:107380. doi:10.1016/j.yebeh.2020.107380. PMID 32882628. verified
- Wu C, Jermakowicz WJ, Chakravorti S, et al. Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: a multicenter study of 234 patients. Epilepsia 2019;60(6):1171–1183. doi:10.1111/epi.15565. PMID 31112302. verified
- Landazuri P, Cheng JJ, Leuthardt E, et al. Interstitial thermal therapy in mesial temporal lobe epilepsy. JAMA Neurol 2025;82(9):915–924. doi:10.1001/jamaneurol.2025.1897. PMID 40622685. verified
- Hu WH, Zhang C, Zhang K, et al. Selective amygdalohippocampectomy versus anterior temporal lobectomy in the management of mesial temporal lobe epilepsy: a meta-analysis of comparative studies. J Neurosurg 2013;119(5):1089–1097. doi:10.3171/2013.8.JNS121854. PMID 24032705. verified
- Jain P, Tomlinson G, Snead C, et al. Systematic review and network meta-analysis of resective surgery for mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2018;89(11):1138–1144. doi:10.1136/jnnp-2017-317783. PMID 29769251. verified
- Medtronic. Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE). ClinicalTrials.gov identifier NCT02844465. Results first posted 2025-01-17. (verified on ClinicalTrials.gov)
- Youngerman BE, Banu MA, Khan F, et al. Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: a multi-centre cohort study. J Neurol Neurosurg Psychiatry 2023;94(11):879–886. doi:10.1136/jnnp-2022-330979. PMID 37336643. verified
- Trivedi AM, Montenegro MA, Gonda D, et al. Laser interstitial thermal therapy for the treatment of mesial temporal lobe epilepsy in children. J Child Neurol 2025;40(5):342–347. doi:10.1177/08830738241312262. PMID 39887192. verified
- Egan RA, Shults WT, So N, et al. Visual field deficits in conventional anterior temporal lobectomy versus amygdalohippocampectomy. Neurology 2000;55(12):1818–1822. doi:10.1212/wnl.55.12.1818. PMID 11134379. verified
Verification (2026-11-16):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed, and every number against the PubMed abstract.
- Reference 4 is online-first, without volume or pages.
- Reference 14 (SLATE): the numbers were checked against the results posted on ClinicalTrials.gov on 2026-11-17. No peer-reviewed outcome article was found on PubMed or Europe PMC. SLATE enrolled adults only.
Caveats:
- The following are standard surgical teaching, not drawn from the cited abstracts:
- the resection extents of ATL (less neocortex on the dominant side);
- the SAH corridors;
- the list of "other risks";
- the "drug-resistant after 2 medications" definition.
- References 1, 2, 5, 6, 8, 10, 12–15 and 17 are mainly adult; pediatric-specific data are references 3, 7, 9, 11 (subgroup) and 16.
- The figure is an original schematic.